このページの翻訳は実験的なもので、現在開発中です。お待ちしております

22nd Century Group 過去の業績

過去基準チェック /06

22nd Century Groupの収益は年間平均-30.3%の割合で減少していますが、 Tobacco業界の収益は年間増加しています。収益は年間17.7% 4.4%割合で増加しています。

主要情報

-26.4%

収益成長率

-3.5%

EPS成長率

Tobacco 業界の成長	18.1%
収益成長率	-0.8%
株主資本利益率	n/a
ネット・マージン	-267.7%
前回の決算情報	30 Jun 2024

Recent updates

Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher

Apr 02

Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook

Aug 20

With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For

Jun 14

Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?

Jan 13

22nd Century adds Creager as distribution partner for its VLN cigarettes in Colorado

Oct 03

収支内訳

22nd Century Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

NasdaqCM:XXII 収益、費用、利益 ( )USD Millions
日付	収益	収益	G+A経費	研究開発費
30 Jun 24	19	-51	17	2
31 Mar 24	19	-63	24	2
31 Dec 23	22	-65	31	3
30 Sep 23	27	-101	33	2
30 Jun 23	27	-41	36	2
31 Mar 23	30	-38	35	3
31 Dec 22	28	-37	32	4
30 Sep 22	49	-47	39	5
30 Jun 22	39	-44	31	5
31 Mar 22	30	-36	28	4
31 Dec 21	31	-33	26	4
30 Sep 21	23	-25	23	4
30 Jun 21	25	-20	19	4
31 Mar 21	28	-21	17	4
31 Dec 20	28	-20	15	4
30 Sep 20	28	-20	13	4
30 Jun 20	27	-26	14	6
31 Mar 20	27	-29	13	7
31 Dec 19	26	-27	13	8
30 Sep 19	26	-29	11	10
30 Jun 19	26	-13	9	12
31 Mar 19	27	-11	9	15
31 Dec 18	26	-8	9	15
30 Sep 18	25	-3	9	13
30 Jun 18	24	-12	9	9
31 Mar 18	20	-9	9	5
31 Dec 17	17	-13	8	3
30 Sep 17	14	-12	8	3
30 Jun 17	13	-11	7	3
31 Mar 17	11	-11	7	2
31 Dec 16	12	-12	8	2
30 Sep 16	12	-12	8	2
30 Jun 16	11	-12	8	2
31 Mar 16	11	-10	8	2
31 Dec 15	9	-11	9	2
30 Sep 15	6	-14	11	1
30 Jun 15	3	-14	12	1
31 Mar 15	1	-14	12	1
31 Dec 14	1	-16	9	1
30 Sep 14	8	-18	6	1
30 Jun 14	8	-30	4	1
31 Mar 14	8	-29	4	1
31 Dec 13	7	-26	4	1

質の高い収益: XXIIは現在利益が出ていません。

利益率の向上: XXIIは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: XXIIは利益が出ておらず、過去 5 年間で損失は年間30.3%の割合で増加しています。

成長の加速: XXIIの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: XXIIは利益が出ていないため、過去 1 年間の収益成長をTobacco業界 ( -2.9% ) と比較することは困難です。

株主資本利益率

高いROE: XXIIの負債は資産を上回っているため、自己資本利益率を計算することは困難です。

22nd Century Group 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Second quarter 2024 earnings released: US$0.36 loss per share (vs US$22.45 loss in 2Q 2023)

22nd Century Group, Inc. to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

22nd Century Group, Inc. to Report Q1, 2024 Results on May 15, 2024

Full year 2023 earnings released: US$3.12 loss per share (vs US$4.65 loss in FY 2022)

22nd Century Group, Inc. to Report Q4, 2023 Results on Mar 28, 2024

Recent updates

New major risk - Share price stability

22nd Century Group, Inc. announced that it expects to receive $1.6815 million in funding

Second quarter 2024 earnings released: US$0.36 loss per share (vs US$22.45 loss in 2Q 2023)

22nd Century Group, Inc. to Report Q2, 2024 Results on Aug 13, 2024

22nd Century Group, Inc. has filed a Follow-on Equity Offering in the amount of $75 million.

22Nd Century Group, Inc. Appoints Robert Manfredonia as Executive Vice President of Sales and Marketing, Effective from August 1, 2024

22nd Century Group, Inc. Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price Requirement

High number of new and inexperienced directors

New major risk - Revenue and earnings growth

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

22nd Century Group, Inc. to Report Q1, 2024 Results on May 15, 2024

22nd Century Group, Inc., Annual General Meeting, Jun 28, 2024

22nd Century Group, Inc. announced that it has received $4.2 million in funding

22nd Century Group, Inc. has filed a Follow-on Equity Offering in the amount of $4.237199 million.

22nd Century Group Receives Deficiency Letter from Nasdaq Regarding Non-Compliance with Nasdaq's Listing Rule 5550(b)(1)

Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher

New major risk - Share price stability

No longer forecast to breakeven

Full year 2023 earnings released: US$3.12 loss per share (vs US$4.65 loss in FY 2022)

22nd Century Group, Inc. to Report Q4, 2023 Results on Mar 28, 2024

22Nd Century Group, Inc. Announces Termination of Peter Ferola as the Chief Legal Officer and Corporate Secretary

High number of new directors

22Nd Century Group, Inc. Appoints Lawrence (Larry) Firestone as Chief Executive Officer

Specialty Acquisition Corporation entered into a equity purchase agreement to acquire Substantially all of GVB hemp/cannabis business from 22nd Century Group, Inc. (NasdaqCM:XXII) and ESI Holdings, LLC for $2.3 million.

Consensus EPS estimates fall by 67%

New major risk - Market cap size

22nd Century Group Receives Non-Compliance Letter from Nasdaq

22nd Century Group, Inc. Continues VLN Expansion, Now Retailing in More Than 5,100 Stores

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

New major risk - Shareholder dilution

22Nd Century Group, Inc. Adds 1,200 Drug Store Locations Selling VLN in Five States

Consensus revenue estimates fall by 11%

Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook

Price target decreased by 27% to US$31.19

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

22nd Century Group, Inc. to Report Q2, 2023 Results on Aug 14, 2023

Pomerantz LLP Announces Pendency of Class Action and Proposed Settlement Involving Purchasers of 22nd Century Group, Inc. Common Stock

High number of new directors

22Nd Century Group, Inc. Announces Chief Executive Officer Changes

22nd Century Group Regains Compliance with Nasdaq Listing Standards

22Nd Century Group, Inc. Announces Its Vln(R) Reduced Nicotine Content C-Stores

New minor risk - Share price stability

22nd Century Announces 1-For-15 Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement

New minor risk - Market cap size

22nd Century Group, Inc. Announces Production of VLN(R) Homogenized Tobacco Leaf Sheet

22nd Century Group, Inc. Announces VLN(R) Products Launch in Nevada to Help Smokers Smoke Less

With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For

22Nd Century Group, Inc. Launches Vln At #1 U.S. C-Store Chain in Texas, California and Florida

Consensus revenue estimates increase by 10%, EPS downgraded

22nd Century Group, Inc. Provides Revenue Guidance for the Full Year 2023

Price target decreased by 11% to US$4.00

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

22nd Century Group, Inc. to Report Q1, 2023 Results on May 09, 2023

Consensus EPS estimates fall by 16%

Full year 2022 earnings: EPS and revenues miss analyst expectations

22nd Century Group, Inc. (NasdaqCM:XXII) acquired Rx Pharmatech Ltd for $0.65 million.

Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?

Forecast to breakeven in 2025

Key Executive notifies of intention to sell stock

22Nd Century Group, Inc. Appoints John J. Miller as an Executive Officer and President of Tobacco

High number of new directors

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

High number of new directors

22nd Century Group, Inc. to Report Q3, 2022 Results on Nov 08, 2022

22nd Century adds Creager as distribution partner for its VLN cigarettes in Colorado

High number of new directors

22Nd Century Group Appoints Lucille S. Salhany to Its Board

22Nd Century Group, Inc. Announces Executive Changes

22nd Century Group to expand sales of VLN tobacco cigarettes

過去基準チェック /06